NCT06696833
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, China, Jiangsu, China
Clinical trial condition
B-Cell Acute Lymphoblastic Leukemia, Adult
Explore clinical trials studying B-Cell Acute Lymphoblastic Leukemia, Adult. Study availability and eligibility vary by location and protocol.
8 public trials
1 recruiting study
B-Cell Acute Lymphoblastic Leukemia, Adult trial results
Not Yet Recruiting
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
NCT07313852
- Conditions
- B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Not Yet Recruiting
Autologous Bedside CD19 CAR T-cell Therapy for B-ALL
NCT07277504
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The General Hospital of Western Theater Command Chengdu, Sichuan, China
Not Yet Recruiting
Allogeneic UCB-derived CAR-T for B-ALL
NCT07256353
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The General Hospital of Western Theater Command Chengdu, Sichuan, China
NCT03160079
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- UCSF Fresno Community Cancer Institute Clovis, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
NCT04788472
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Active, Not Recruiting
Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia
NCT07199855
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Active, Not Recruiting
CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
NCT04214886
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +19 more
- Locations
-
- Loyola University Maywood, Illinois, United States